Patent · US Active

Collagen carrier of therapeutic genetic material and method

US8911763B2 · kind B2 · utility

0Cited by

41References

12Claims

0Family size

Assignee

Ed. Geistlich Soehne AG fuer Chemistrie Industrie · CH

Inventors

Peter Geistlich · Stansstad, CH
Lothar Schloesser · Darmstadt, DE

Key dates

Filing date	Oct 30, 2007
Grant date	Dec 16, 2014
Priority date	—
Expiry date	Oct 5, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2430/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A collagen matrix material is charged with a cell growth-promoting derived nucleic acid sequence. The nucleic acid sequence-charged collagen matrix material may be utilized in a method of promoting regeneration of surface cartilage of a joint. In the method, an area of injury is covered with the nucleic acid sequence-charged collagen matrix material, the collagen matrix material is fixed over the area to be treated, and the area is allowed to heal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.